P H de Mulder

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.

A. Horwich, D.Th. Sleijfer, Sophie D. Fosså et al. · Journal of Clinical Oncology · 1997 · 331 citations

Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom.

Sophie D. Fosså, Stuart Kaye, Graham M. Mead et al. · Journal of Clinical Oncology · 1998 · 145 citations

Vaccination of Patients With Metastatic Renal Cell Carcinoma With Autologous Dendritic Cells Pulsed With Autologous Tumor Antigens in Combination With Interleukin-2: A Phase 1 Study

Jeannette Oosterwijk‐Wakka, Dorien M. Tiemessen, Ivar Bleumer et al. · Journal of Immunotherapy · 2002 · 99 citations

Intratumoral Administration of Recombinant Human Interleukin 12 in Head and Neck Squamous Cell Carcinoma Patients Elicits a T-Helper 1 Profile in the Locoregional Lymph Nodes

Carla M. van Herpen, Maaike W.G. Looman, Marijke I. Zonneveld et al. · Clinical Cancer Research · 2004 · 87 citations · Full text

T-regulatory Cell, Immunology, Immunoediting +18

Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication

Wim H.J. Kruit, K. Punt, S.H. Goey et al. · Cancer · 1994 · 55 citations · Full text